FINAL ANNOUNCEMENT: More than 35 Early- to Late-Stage Med Device Companies Seeking Funding and/or Strategic Partnership Presenting at Medtech Insight and Windhover Information's ''In3 Europe'' Investment and Partnering Conference
April 29-30, 2008, Paris, France, The Hilton Paris
NEWPORT BEACH, Calif.--(Business Wire)--
Medtech Insight, a division of Windhover Information, Inc. and a
leading provider of business information for the medical device
industry, has announced that more than 35 early- to late-stage medical
device companies from around the world are confirmed to present at its
"Investment In Innovation (In3) Europe" conference, being held April
29-30, 2008 at The Hilton Paris in Paris, France. In3 Europe - the
company's 30th In3 conference - will showcase highly promising
start-up med device companies from around the world presenting to an
audience of senior business development and investment executives from
the leading medical technology and healthcare investment firms
worldwide, for purposes of raising funding or forming strategic
partnerships. Regularly updated event details can be viewed at
www.windhover.com/in3europe08.
Presentations from a carefully selected group of cutting-edge,
early- to late-stage companies will encompass a wide variety of
high-growth device market sectors. Presenters confirmed to date
include Arterial Remodeling Technologies, Axess Vision Technology,
BiancaMed Limited, Biomedix SA, Biospace, Cardiatis, Cardio3
Biosciences SA, CardioLa, Ltd., Ceragenix Pharmaceuticals,
Ceramconcept LLC, ES Vascular Ltd., Gendel Ltd., InitiaRT, Intellwave,
LLC, JenaValve Technology GmbH, MagForce Nanotechnologies GmbH,
Mini-Lap, Inc., MINVASYS, mNemoscience GmbH, Nanobiotix, NanoPowers
SA, Nerites Corporation, OTR3, Ovalum Ltd., Photo Dynamic Therapy,
Praxim, SA, PreMD Inc., ProRhythm, Inc., Retina-Implant GmbH, Science
& Technology International, Small Bone Innovations, LLC, Symetis SA,
SyntheMed, Inc., Vivolution A/S, Vivoxid, and Xylos Corporation.
The In3 Europe format will include focused 10-minute presentations
by a senior executive from each presenting company to our full
audience, each followed immediately by one-on-one meetings with
interested parties in private breakout rooms. The event will also
feature an insightful Keynote Presentation by David Cassak, Managing
Partner at Windhover Information, entitled "State of the Medical
Device Industry," and an informative and interactive Panel Discussion,
"Trends in European Dealmaking and Investing," with esteemed panelists
to include Christophe Douat, Partner, Matignon Investissement &
Gestic; Dr. Olivier Litzka, Partner, Edmond de Rothschild Investment
Partners; Antoine Papiernik, Managing Partner, Sofinnova Partners;
Yuval Binur, Founder & General Partner, Accelerated Technologies
Partners; and Thom Rasche, Venture Partner, Earlybird Ventures. The
program will also feature a presenting company product
exhibition/networking reception, and educational workshops. In3 Europe
co-sponsoring companies include Business Wire, MDMA, Ronald Trahan
Associates, Summit Corporate Services, and F-D-C Report Inc.'s The
Gray Sheet.
In3 Europe's growing attendee list includes a robust line-up of
buy-side/investors from around the world. A sample of companies
sending their teams include: Abingworth Management Ltd., ABSF
Consulting GmbH, Accelerated Technologies, Inc., Accuitive Medical
Ventures, Aelios Finance, Astra Tech AB, Averion Europe GmbH, Baylor
College of Medicine, Banexi Ventures Partners, Bayer Innovation, GmbH,
BayTech Venture Capital, BD Medical Pharmaceutical Systems, BioMedic
Insure, Boston Scientific International, SA, Boston Scientific
Technologie Zentrum GmbH, Ceramconcept LLC, Credit Agricole Private
Equity, Delta Partners, Earlybird Ventures, Edwards Lifesciences
Corporation, Enterprise Ireland, Ethicon, ev3 Europe SAS, Flanders
Investment & Trade Agency, Fravimed, Gilde Healthcare Partners,
Johnson & Johnson Medical Asia Pacific, Johnson & Johnson Wound
Management, Kimberly-Clark Health Care, Kobayashi Pharmaceuticals of
America, Kyphon, Inc., LMA International NV, Matignon Technologies
FCPR, MedNest LLC, Medpass International, Medrad, Inc., Medtronic
Europe Sarl, Moscow Investment and Export Promotion Agency, NBGI
Ventures, Nippon Sigmax Company, Ltd., Noble Fund Managers, Novartis
Venture Fund, Oakes, Lyman & Company, Ltd., Orbimed Advisors, OTC
Asset Management, PA Consulting, Pfizer, Plus Orthopedics AG/Smith &
Nephew, Polaris Venture Partners, Prism Venture Partners, Quintiles
Consulting, Rothschild Gestion-Paris, Rothschild Investment Partners,
Ruston Poole International, Scottish Equity Partners, Smith & Nephew,
Sofinnova Partners, Stryker Corporation, Teijin Pharma, Ltd., Truffle
Capital, University of Oxford, Wellington Partners, Zarlink
Semiconductor, and Zimmer GmbH, among many others.
Medtech Insight and its parent company, Windhover Information,
have established a reputation as holding the premier forums worldwide
for discerning senior executives in the medical device, diagnostics,
biotech, and pharmaceutical business development and investment
communities to meet and screen promising early-stage life sciences
companies in need of funding, acquisition and/or strategic
partnership, and to network with key decision makers in the industry.
Over 1350 emerging medical technology company presenters and over 7200
attendees have participated at In3 events over the past 7 years.
Medtech Insight and Windhover Information will also be holding
their highly anticipated "In3 Medical Device Summit" conference in San
Francisco, CA, June 17-19, featuring over 50 medtech company
presentations in 3 concurrent specialty tracks, as well as their
annual "In3 East" conference in Boston, MA, October 22-24. For more
information on these upcoming events, please call Medtech Insight or
visit the company's website at www.medtechinsight.com.
About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the
leading provider of business information and market intelligence for
the medical technology marketplace. For more on the company's products
and services, please see www.medtechinsight.com.
Medtech Insight, a division of Windhover Information Inc.
Kristy Grimes, 480-985-9512
or 888-202-5939 toll-free in the U.S.
kristy@medtechinsight.com
www.windhover.com/in3europe08
Copyright Business Wire 2008
